Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24 Weeks, Multi-centers, Single Arm Phase IV Study to Evaluate the Safety of 'Shinbaro Capsule' Compared With Historical Data of 'Celebrex Capsule' in Patients With Osteoarthritis

NCT01604239 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT01604239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01604239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24 Weeks, Multi-centers, Single Arm Phase IV Study to Evaluate the Safety of 'Shinbaro Capsule' Compared With Historical Data of 'Celebrex Capsule' in Patients With Osteoarthritis
Lead sponsor
Green Cross Corporation
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2012
Completion date
June 30, 2013
Enrollment
761 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis